Effect of changing from first- to second- line antiretroviral therapy on renal function : a retrospective study based on data from a single health facility in Namibia

Kalemeera, Francis and Mbango, Christofina and Mubita, Mwangana and Naikaku, Esther and Gaida, Razia and Godman, Brian (2016) Effect of changing from first- to second- line antiretroviral therapy on renal function : a retrospective study based on data from a single health facility in Namibia. Expert Review of Anti-infective Therapy, 14 (8). pp. 777-783. ISSN 1744-8336 (https://doi.org/10.1080/14787210.2016.1202759)

[thumbnail of Kalemeera-etal-ERAIT-2016-Effect-of-changing-from-first-to-second-line-antiretroviral-therapy-on-renal]
Preview
 Text. Filename: Kalemeera_etal_ERAIT_2016_Effect_of_changing_from_first_to_second_line_antiretroviral_therapy_on_renal.pdf
Accepted Author Manuscript
Download (719kB)| Preview

Abstract

Tenofovir disoproxil fumarate (TDF) and lopinavir/ritonavir (LPV/r) can cause renal impairment with this combination co-administered during second-line combination antiretroviral therapy (cART) potentially associated with greater risk of nephrotoxicity. Objective: Assess effects of second-line cART on renal function. Methods: Retrospective longitudinal study in patients receiving cART. Results: 71 patients received TDF, zidovudine or stavudine, each combined with 3TC/NVP or 3TC/ EFV. Before second-line cART, 46.5% had abnormal kidney function. First-line cART had no relationship with calculated creatinine clearance (CrCl). During second-line cART, more males than females had abnormal renal function and more females experienced increases in CrCl. Calculated CrCl during second-line cART related strongly with CrCl during first-line cART; time spent on cART weak relationship with CrCl. Conclusion: Patients on first-line cART for several years without renal impairment may experience new onset impairment during cART. Patients with pre-existing renal impairment just before switching to second-line cART may experience a further decline.

  • Item type:Article
    ID code:56694
    Dates:
    Date
    Event
    14 July 2016
    Published
    14 June 2016
    Accepted
    25 January 2016
    Submitted
    Notes:Kalemeera, F., Mbango, C., Mubita, M., Naikaku, E., Gaida, R., & Godman, B. (2016). Effect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia. Expert Review of Anti-Infective Therapy, 14(8), 777–783. https://doi.org/10.1080/14787210.2016.1202759
    Subjects:Medicine > Pharmacy and materia medica
    Medicine
    Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
    Depositing user: Pure Administrator
    Date deposited:17 Jun 2016 15:18
    Last modified:11 Nov 2024 11:27
    Related URLs:
    URI:https://strathprints.strath.ac.uk/id/eprint/56694
CORE (COnnecting REpositories)